ROIpad ← Back to Search

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Keyword: Risk Factor

Publisher: Science Daily

Published: Jun 6, 2026

Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 wom… [+5850 chars]

Read Full Story ↗

Related Content

Related Story Testosterone is being overprescribed to men — here's who should take it, and when it backfires

Business Insider
Related Story A 49-year-old triathlete suddenly lost vision in one eye. He was diagnosed with stage 4 lung cancer, despite never smoking.

Business Insider
Related Story Why GLP-1 drugs might reduce cancer risk

Scientific American